stockportfolio.pro
Stocks / ENOV vs TDOC
ENOV vs TDOC
Enovis Corporation and Teladoc Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Enovis Corporation (ENOV) | Teladoc Health, Inc. (TDOC) | |
|---|---|---|
| Market cap | $1.3B | $1.3B |
| Revenue (latest FY) | $2.25B | $2.53B |
| Net income (latest FY) | $-1.18B | $-200.32M |
| Revenue growth (5y CAGR) | 14.9% | 18.3% |
| Net margin | -52.7% | -7.9% |
| Return on equity | -79.5% | -14.5% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 5 | 0 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ENOV — free Open TDOC — freeFrequently asked questions
Which is bigger, ENOV or TDOC?
Enovis Corporation is larger by market capitalization — $1.3B versus $1.3B.
Which grows faster, ENOV or TDOC?
Over the last five fiscal years, Teladoc Health, Inc. grew revenue faster — 18.3%/yr versus 14.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.